Amphotericin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-365

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 55150-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cross Section Of Liposome (Amphotericin Fig1)

Illustration showing a cross section view of a liposome with labeled phospholipid bilayer and amphotericin B molecules embedded inside. The diagram highlights the structural components of the liposome relevant to the drug Amphotericin B.*

FDA Label Image

Mean Change In Creatinine Over Time In Study 94-0-002 (Amphotericin Fig2)

A line graph showing mean change in creatinine levels (mg/dL) over weeks on study for two Amphotericin B injection dosing regimens: liposome 3 mg/kg/day and conventional 0.6 mg/kg/day. The x-axis represents weeks 0 to 5, and the y-axis shows mean creatinine change from 0 to 0.7 mg/dL. Data points are labeled with sample sizes at each time point.*

FDA Label Image

Mean Creatinine Concentrations Over Time (Amphotericin Fig3)

A line graph showing mean creatinine concentration (mg/dL) over days of test up to 50 days. Two data series are displayed: patients whose pretreatment creatinine was >1.7 mg/dL with values starting above 3 mg/dL and decreasing over time, and all episodes which show lower, relatively stable creatinine levels near 1.5 mg/dL. Data points are annotated with sample sizes.*

FDA Label Image

Package Label-principal Display Panel-50 mg Per Vial (Container Label)

Label for Amphotericin B Liposome for Injection, 50 mg per vial, lyophilized powder for solution by Eugia US LLC. Intended for intravenous infusion only, single-dose vial, sterile and nonpyrogenic. Includes storage instructions and distributor address in New Jersey.*

FDA Label Image

Package Label-principal Display Panel-50 mg Per Vial (Container-Carton (1 Vial))

Packaging label for Amphotericin B Liposome for Injection 50 mg per vial, a lyophilized powder injection for intravenous infusion only. The label states it is a single-dose vial distributed by Eugia US LLC. It includes storage information, warnings about reconstitution and substitution, and a barcode.*

FDA Label Image

Chemical Strucutre (Amphotericin Str)

Chemical structure diagram of Amphotericin B, depicting its detailed molecular arrangement including hydroxyl, amine, and methyl groups connected by a long polyene chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.